{"page_content": "Product Quality  \n& Safety \nOur growing menu of diagnostic tests \nleverages advances in molecular science and \nmachine learning technology to improve care \nfor patients, enabling them to avoid risky, \ncostly procedures and interventions, and \naccelerate time to appropriate treatment. \nWe collect extensive clinical utility data to \ndemonstrate our tests\u2019 ability to provide \ntrustworthy and actionable answers \nthroughout the patient journey. As a part of \nthis process, we have implemented rigorous \nquality control processes to validate the safety \nof our diagnostic tests. Our diagnostic tests enable \npatients to avoid risky, costly \nprocedures and interventions, \nand accelerate time to \nappropriate treatment.\n27\n", "metadata": {"source": "NASDAQ_VCYT_2023.pdf", "page": 27, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}